Medistem, Inc. logo
Intrexon to Acquire Medistem to Generate Multipotent Cells
December 20, 2013 10:44 ET | Medistem, Inc.
GERMANTOWN, Md. and SAN DIEGO, Dec. 20, 2013 (GLOBE NEWSWIRE) -- Intrexon Corporation (NYSE:XON), a leader in synthetic biology, today announced that it has entered into a definitive agreement to...
Medistem, Inc. logo
Medistem Begins Trading on the OTCQB
November 14, 2013 09:00 ET | Medistem, Inc.
SAN DIEGO, Nov. 14, 2013 (GLOBE NEWSWIRE) -- Medistem Inc. (OTCQB:MEDS), today announced that its shares of common stock are now listed on the OTC Markets Group's OTCQB marketplace. The company's...
Medistem, Inc. logo
Medistem Announces Preclinical Data on Type 1 Diabetes and Filing of Intellectual Property
October 03, 2013 11:50 ET | Medistem, Inc.
SAN DIEGO, Oct. 3, 2013 (GLOBE NEWSWIRE) -- Medistem, Inc. (Pink Sheets: MEDS), announced today that it filed patent application #61/885909 covering immune modulatory aspects of ERC-124, the Company's...
Medistem, Inc. logo
Medistem to Present at Aegis Capital 2013 Healthcare Conference
September 25, 2013 11:18 ET | Medistem, Inc.
SAN DIEGO, Sept. 25, 2013 (GLOBE NEWSWIRE) -- Medistem, Inc. (Pink Sheets:MEDS), today announced that its President and CSO, Thomas Ichim, Ph.D., will present at the Aegis Capital 2013 Healthcare...